dc.contributor.author |
Rubio-Martinez, Luis M.
|
|
dc.contributor.author |
Elmas, Colette R.
|
|
dc.contributor.author |
Black, Belinda
|
|
dc.contributor.author |
Monteith, Gabrielle
|
|
dc.date.accessioned |
2013-02-07T09:02:56Z |
|
dc.date.available |
2013-02-07T09:02:56Z |
|
dc.date.issued |
2012-12 |
|
dc.description.abstract |
OBJECTIVE—To describe the clinical use of regional limb perfusion with antimicrobials
(A-RLP), complications, and outcome in a large series of patients.
DESIGN—Retrospective case series.
ANIMALS—174 horses.
PROCEDURES—Medical records of horses treated with A-RLP between 1999 and 2009 were
reviewed. Signalment, primary complaint, horse use, etiology, duration of clinical signs,
previous treatment, structures involved, concurrent conditions, A-RLP characteristics, additional
treatments, complications, and outcome were recorded. At long-term follow-up, 2
outcomes were investigated: survival rate and return to previous use at the same or higher
level. Univariate and multivariate logistic regression analyses were conducted.
RESULTS—Group 1 (96 horses) included septic synovitis. Group 2 (50 horses) included extrasynovial
lacerations (23 horses) and fresh, minimally contaminated intrasynovial lacerations
without evidence of established synovial infection (27 horses). Group 3 (28 horses) included
miscellaneous other conditions. Only minor complications were reported in 12.26% of
horses that received IV (n = 155) and 33% of horses that received intraosseous (27) A-RLP.
Horses with septic synovitis had a lower survival rate (53.43%) than did horses with lacerations
(91.89%). Within group 2, no significant differences in short- or long-term outcomes
were found between horses with extrasynovial and fresh, minimally contaminated intrasynovial
lacerations. For the horses returning to previous use, 80% of horses with septic
synovitis and 72.72% of horses with lacerations were performing at the same or higher
level at the time of follow-up.
CONCLUSIONS AND CLINICAL RELEVANCE—The results of the present study indicated that
A-RLP is a safe technique with minimal adverse effects. The IV route presented fewer complications
than intraosseous injection. Horses with infection of synovial structures had a
lower survival rate than did those with acute, minimally contaminated intrasynovial lacerations.
The latter had a similar prognosis for horses with extrasynovial lacerations treated with
A-RLP. |
en |
dc.description.librarian |
am2013 |
en |
dc.description.librarian |
mn2013 |
|
dc.description.uri |
http://avmajournals.avma.org/loi/javma |
en |
dc.identifier.citation |
Rubio-Martinez, LM, Elmas, CR, Black, B & Monteith, G 2012, 'Clinical use of antimicrobial regional limb perfusion in horses : 174 cases (1999–2009)', JAVMA_Journal of the American Veterinary Medical Association, vol. 241, no. 12, pp. 1650-1658. |
en |
dc.identifier.issn |
003-1488 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/20966 |
|
dc.language.iso |
en |
en |
dc.publisher |
American Veterinary Medical Association |
en |
dc.rights |
American Veterinary Medical Association |
en |
dc.subject |
Horses |
en |
dc.subject |
Regional limb perfusion |
en |
dc.subject.lcsh |
Anti-infective agents in veterinary medicine |
en |
dc.subject.lcsh |
Horses -- Diseases |
en |
dc.title |
Clinical use of antimicrobial regional limb perfusion in horses : 174 cases (1999–2009) |
en |
dc.type |
Article |
en |